* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:DMS1 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Diagnostic Medical Systems's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (STU:DMS1) has a Buyback Yield % of -21.07 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Diagnostic Medical Systems and its competitors. According to the industry distribution chart, Diagnostic Medical Systems ranks #276 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 79.8%.
Is Diagnostic Medical Systems' Buyback Yield % too high?
Diagnostic Medical Systems' current Buyback Yield % is -21.07. Based on the distribution chart, Diagnostic Medical Systems ranks #276 out of 346 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #276 out of 346 companies for Buyback Yield %. This places Diagnostic Medical Systems in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current Buyback Yield % is -21.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (STU:DMS1) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.20 — trading 4.8% above its estimated fair value. The current Buyback Yield % is -21.07. Diagnostic Medical Systems' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Diagnostic Medical Systems (STU:DMS1), the current Buyback Yield % is -21.07 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (STU:DMS1) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.20 is trading 4.8% above its estimated GF Value™ of €1.14.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for STU:DMS1:
Buyback Yield %: -21.07
GF Value™: €1.14 vs. price of €1.20 (4.8% above fair value)
No single metric tells the full story. See the STU:DMS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
47GF Score
Get the complete analysis for STU:DMS1
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:DMS1 has been successfully added to your 
